A comparison of midazolam with fentanyl or pethidine as a sedation for colonoscopy.

ISRCTN ISRCTN60349285
DOI https://doi.org/10.1186/ISRCTN60349285
Secondary identifying numbers N0649155306
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
12/04/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Alistair McNair
Scientific

Consultant Gastroenetrologist
Queen Elizabeth Hospital NHS Trust
Stadium Road
Woolwich
London
SE18 4QH
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeNot Specified
Scientific title
Study objectivesIs there a significant difference between midazolam + fentanyl or midazolam + pethidine for colonoscopy sedation in terms of discomfort experienced by patients.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Colonoscopy
InterventionPatients must receive sedation for colonoscopy. They will be randomised to receive one of the two drug combinations, both of which are already used in this Trust. There will be no cost, safety or training implications, as the study will use existing practice and protocols. Data will be collected to compare efficacy, safety and acceptability of the two combinations.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)midazolam, fentanyl, pethidine
Primary outcome measure1. Patient pain experienced/recalled
2. Comparison between two sedation regimes
Secondary outcome measures1. Experience of pain related to Endoscopist
2. Patient expectation pre-endoscopy
3. Friendliness of staff
4. Incidence of adverse events during endoscopy
5. Need for more sedative
6. Desaturation
7. Agitation
8. Time taken for endoscopy (completion rate)
9. Time taken for recovery
10. Does patient's perception differ from Endoscopist, Nurse?
Overall study start date20/02/2005
Completion date31/12/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants2000
Key inclusion criteriaAll patients attending for colonoscopy (approx 2000 per year) will be eligible.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment20/02/2005
Date of final enrolment31/12/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Consultant Gastroenetrologist
London
SE18 4QH
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Queen Elizabeth Hospital NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2009 Yes No